HomePublications

Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK

Research output: Contribution to journalArticle

Open Access permissions

Open

Documents

Links

DOI

Authors

  • Walter Mandaliti
  • Ridvan Nepravishta
  • Francesca Pica
  • Paola Sinibaldi Vallebona
  • Enrico Garaci
  • Maurizio Paci

Organisational units

Abstract

Thymosin α1 (Tα1), is a peptidic hormone, whose immune regulatory properties have been demonstrated both in vitro and in vivo and approved in different countries for treatment of several viral infections and cancers. Tα1 assumes a conformation in negative membranes upon insertion into the phosphatidylserine exposure as found in several pathologies and in apoptosis. These findings are in agreement with the pleiotropy of Tα1, which targets both normal and tumor cells, interacting with multiple cellular components, and have generated renewed interest in the topic. Hyaluronan (HA) occurs ubiquitously in the extracellular matrix and on cell surfaces and has been related to a variety of diseases, and developmental and physiological processes. Proteins binding HA, among them CD44 and the Receptor for HA-mediated motility (RHAMM) receptors, mediate its biological effects. NMR spectroscopy indicated preliminarily that an interaction of Tα1 with HA occurs specifically around lysine residues of the sequence LKEKK of Tα1 and is suggestive of a possible interference of Tα1 in the binding of HA with CD44 and RHAMM. Further studies are needed to deepen these observations because Tα1 is known to potentiate the T-cell immunity and anti-tumor effect. The binding inhibitory activity of Tα1 on HA-CD44 or HA-RHAMM interactions can suppress both T-cell reactivity and tumor progression.

Details

Original languageEnglish
Article number1843
JournalMolecules
Volume22
Issue number11
DOIs
StatePublished - 27 Oct 2017
Peer-reviewedYes

Keywords

    Research areas

  • Thymosin α1, CD44, RHAMM, thymic hormone

View graph of relations

ID: 122590697